BPD Symposium: Novel Modalities in Biotechnology
The landscape of biopharma has dramatically changed in recent years, moving beyond protein-based products to include modalities such as antisense oligonucleotides, gene therapy and cell therapy products. In RTP, universities and biotech companies are working hard to make these new technologies work for patients who need them. On November 29th, please join the Biomanufacuting and Process Development (BPD) exchange group for an exciting afternoon of networking and a symposium where local leaders share successes and challenges in manufacturing these new modalities.
Agenda
| 12:30 - 1:00 p.m | Registration and networking |
| 1:00 - 1:05 p.m. | Introduction |
| 1:05 - 1:40 p.m. |
“Preparing for the Future Growth of Oligonucleotide Therapies” Sheron Branham, MBA |
| 1:40 - 2:15 p.m. |
“Scaling Up of Stem Cell Production for Research and the Clinic” Barbara Ressler, PhD |
| 2:15 - 2:45 p.m. | Networking break and refreshments |
| 2:45 - 3:20 p.m. |
"A Rapid Affinity Purification Technology and Supply Platform to Address the Manufacturing Complexities of Novel Modalities" Dan Freymeyer |
| 3:20 - 3:55 p.m. |
"Challenges in Allogenic CAR T Cell Manufacture" Brent Rice |
| 3:55 - 4:30 p.m. | Networking |
| 4:30 p.m. | Adjourn |
Directions/Parking
NCBiotech
15 T.W. Alexander Drive
Research Triangle Park, NC 27709